Leo Pharmaceutical Products, Ltd. v. Kappos
Leo Pharmaceutical Products, Ltd. v. Kappos
Opinion
Case: 12-1520 Document: 31 Page: 1 Filed: 09/27/2012
NOTE: This order is nonprecedential.
WIniteb ~tate5 (!Court of ~peaI5 for tbe jfeberaI (!Circuit LEO PHARMACEUTICAL PRODUCTS, LTD. Appellant, v. DAVID J. KAPPOS, DIRECTOR, UNITED STATES PATENT AND TRADEMARK OFFICE, Appellee, AND GALDERMA R&D, Appellee.
2012-1520 (Reexamination No. 95/000,153)
Appeal from the United States Patent and Trademark Office, Board of Patent Appeals and Interferences.
ON MOTION
ORDER Case: 12-1520 Document: 31 Page: 2 Filed: 09/27/2012
LEO PHARMACEUTICAL PRODUCTS V. KAPpos 2
The Director of the United States Patent and Trade- mark Office and Galderma R&D ("Galderma") each move for a 50-day extension of time, until November 16, 2012, to file their principal briefs. Leo Pharmaceutical Prod- ucts, Ltd. opposes.
Upon consideration thereof, IT Is ORDERED THAT: The motions are granted. Galderma's and the Direc- tor's principal briefs are due November 16, 2012.
FOR THE COURT
SEP 21 2012 /s/ Jan Horbaly Date Jan Horbaly Clerk cc: Andrew D. Meikle, Esq.
Raymond T. Chen, Esq.
Martin B. Pavane, Esq. COuJ't~~ u.s.11fEFEDERAtCrRCUITfOR s27 SEP 272012 JAN HORBALY ClERK
Case-law data current through December 31, 2025. Source: CourtListener bulk data.